Skip to main content
Fig. 2 | Malaria Journal

Fig. 2

From: Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

Fig. 2

Evaluation of safety, effectiveness and impact using data collected as part of the RTS,S/AS01E post-approval plan. AESI adverse events of special interest. Asterisk indicates the potential risk of meningitis will be monitored on ongoing basis using the maximized sequential probability ratio test (MaxSPRT) method

Back to article page